Table 2 Clinical characteristics of study participants in public hospitals, Addis Ababa Ethiopia, 2020(n = 386)
Variable | Category | Frequency(n) | Percent (%) |
|---|---|---|---|
Cancer type | Lung cancer | 28 | 7.3 |
Breast cancer | 162 | 42.0 | |
Colorectal cancer | 71 | 18.4 | |
Cervical cancer | 42 | 10.8 | |
Sarcoma | 28 | 7.3 | |
Esophageal cancer | 23 | 6.0 | |
Gastric cancer | 11 | 2.8 | |
Others* | 21 | 5.4 | |
Cancer stage | Stage I | 45 | 11.7 |
Stage II | 71 | 18.4 | |
Stage III | 131 | 33.9 | |
Stage IV | 139 | 36.0 | |
Length of diagnosis |  < 12 months | 193 | 50.0 |
 > 12 months | 193 | 50.0 | |
Co-morbidity | Yes | 135 | 35.0 |
No | 251 | 65.0 | |
Treatment received | Radiation | 7 | 1.8 |
Surgery | 9 | 2.3 | |
Chemotherapy | 184 | 47.7 | |
Surgery plus chemotherapy | 118 | 30.6 | |
Radiation plus surgery plus chemotherapy | 34 | 8.8 | |
Surgery plus radiation | 34 | 8.8 |